Structural and Functional Characterization of the Interdomain Interaction in the Mineralocorticoid Receptor
Overview
Molecular Biology
Affiliations
The mineralocorticoid receptor (MR) plays a central role in electrolyte homeostasis and in cardiovascular disease. We have previously reported a ligand-dependent N/C-interaction in the MR. In the present study we sought to fully characterize the MR N/C-interaction. By using a range of natural and synthetic MR ligands in a mammalian two-hybrid assay we demonstrate that in contrast to aldosterone, which strongly induces the interaction, the physiological ligands deoxycorticosterone and cortisol weakly promote the interaction but predominantly inhibit the aldosterone-mediated N/C-interaction. Similarly, progesterone and dexamethasone antagonize the interaction. In contrast, the synthetic agonist 9alpha-fludrocortisol robustly induces the interaction. The ability of the N/C interaction to discriminate between MR agonists suggests a subtle conformational difference in the ligand-binding domain induced by these agonists. We also demonstrate that the N/C interaction is not cell specific, consistent with the evidence from a glutathione-S-transferase pull-down assay, of a direct protein-protein interaction between the N- and C-terminal domains of the MR. Examination of a panel of deletions in the N terminus suggests that several regions may be critical to the N/C-interaction. These studies have identified functional differences between physiological MR ligands, which suggest that the ligand-specific dependence of the N/C-interaction may contribute to the differential activation of the MR that has been reported in vivo.
The mineralocorticoid receptor forms higher order oligomers upon DNA binding.
Fettweis G, Johnson T, Almeida-Prieto B, Weller-Perez J, Presman D, Hager G Protein Sci. 2023; 33(3):e4890.
PMID: 38160317 PMC: 10868434. DOI: 10.1002/pro.4890.
Aldosterone: Renal Action and Physiological Effects.
Johnston J, Welch A, Cain B, Sayeski P, Gumz M, Wingo C Compr Physiol. 2023; 13(2):4409-4491.
PMID: 36994769 PMC: 11472823. DOI: 10.1002/cphy.c190043.
Paul S, Wingenfeld K, Otte C, Meijer O Br J Pharmacol. 2022; 179(13):3205-3219.
PMID: 35297038 PMC: 9323486. DOI: 10.1111/bph.15835.
Kowalczyk W, Waliszczak G, Jach R, Dulinska-Litewka J Cancers (Basel). 2021; 13(19).
PMID: 34638264 PMC: 8507808. DOI: 10.3390/cancers13194779.
Munier C, De Maria L, Edman K, Gunnarsson A, Longo M, Mackintosh C J Biol Chem. 2021; 296:100551.
PMID: 33744286 PMC: 8080530. DOI: 10.1016/j.jbc.2021.100551.